Intact Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Sell
11,900
-3,400
-22% -$1.16M 0.12% 146
2026
Q1
$5.38M Hold
15,300
0.15% 129
2025
Q4
$5.01M Sell
15,300
-7,100
-32% -$2.25M 0.14% 131
2025
Q3
$6.32M Sell
22,400
-3,200
-13% -$928K 0.19% 100
2025
Q2
$7.15M Sell
25,600
-10,800
-30% -$3.06M 0.24% 94
2025
Q1
$11.3M Sell
36,400
-700
-2% -$207K 0.39% 70
2024
Q4
$9.67M Buy
37,100
+11,300
+44% +$3.35M 0.34% 81
2024
Q3
$8.31M Buy
25,800
+500
+2% +$164K 0.28% 91
2024
Q2
$7.9M Sell
25,300
-18,700
-43% -$5.49M 0.3% 81
2024
Q1
$12.5M Buy
44,000
+26,100
+146% +$7.64M 0.49% 40
2023
Q4
$5.16M Hold
17,900
0.21% 99
2023
Q3
$4.81M Sell
17,900
-3,400
-16% -$848K 0.21% 92
2023
Q2
$4.73M Sell
21,300
-11,900
-36% -$2.76M 0.19% 107
2023
Q1
$8.03M Sell
33,200
-2,300
-6% -$565K 0.33% 77
2022
Q4
$9.32M Buy
35,500
+5,700
+19% +$1.53M 0.4% 66
2022
Q3
$6.72M Hold
29,800
0.22% 91
2022
Q2
$7.25M Sell
29,800
-9,600
-24% -$2.35M 0.23% 91
2022
Q1
$9.52M Sell
39,400
-26,000
-40% -$5.97M 0.24% 90
2021
Q4
$14.7M Buy
65,400
+32,200
+97% +$6.8M 0.37% 62
2021
Q3
$7.06M Hold
33,200
0.2% 91
2021
Q2
$8.09M Hold
33,200
0.23% 89
2021
Q1
$8.26M Sell
33,200
-5,200
-14% -$1.24M 0.25% 87
2020
Q4
$8.83M Hold
38,400
0.29% 78
2020
Q3
$9.75M Sell
38,400
-9,300
-19% -$2.3M 0.34% 61
2020
Q2
$11.2M Sell
47,700
-3,100
-6% -$707K 0.42% 48
2020
Q1
$10.3M Buy
50,800
+25,500
+101% +$5.57M 0.45% 50
2019
Q4
$6.09M Sell
25,300
-3,100
-11% -$683K 0.21% 81
2019
Q3
$5.5M Sell
28,400
-20,000
-41% -$3.84M 0.2% 91
2019
Q2
$8.92M Buy
48,400
+4,400
+10% +$788K 0.32% 65
2019
Q1
$8.36M Buy
44,000
+6,700
+18% +$1.28M 0.3% 68
2018
Q4
$7.26M Hold
37,300
0.29% 72
2018
Q3
$7.73M Sell
37,300
-4,000
-10% -$788K 0.28% 72
2018
Q2
$7.62M Sell
41,300
-4,100
-9% -$725K 0.27% 72
2018
Q1
$7.74M Buy
45,400
+43,800
+2,738% +$8.04M 0.3% 66
2017
Q4
$278K Hold
1,600
0.01% 195
2017
Q3
$298K Buy
+1,600
New +$283K 0.01% 193
2016
Q3
Sell
-2,200
Closed -$335K 270
2016
Q2
$335K Sell
2,200
-500
-19% -$77.7K 0.01% 224
2016
Q1
$405K Sell
2,700
-1,700
-39% -$253K 0.02% 206
2015
Q4
$714K Sell
4,400
-600
-12% -$94.3K 0.03% 159
2015
Q3
$690K Sell
5,000
-1,300
-21% -$205K 0.03% 156
2015
Q2
$967K Sell
6,300
-500
-7% -$80.1K 0.04% 145
2015
Q1
$1.09M Hold
6,800
0.04% 138
2014
Q4
$1.08M Hold
6,800
0.04% 139
2014
Q3
$955K Hold
6,800
0.04% 139
2014
Q2
$805K Hold
6,800
0.03% 138
2014
Q1
$839K Hold
6,800
0.04% 126
2013
Q4
$776K Hold
6,800
0.04% 112
2013
Q3
$761K Buy
6,800
+4,100
+152% +$445K 0.04% 108
2013
Q2
$266K Buy
+2,700
New +$280K 0.01% 108

Other funds holding AMGN

Intact Investment Management's AMGN Position: Q2 2026 in Review

Intact Investment Management reduced its Amgen (AMGN) stake by 22% in Q2 2026, selling an estimated $1.16M and leaving 11,900 shares worth $4.31M. The position accounts for 0.12% of the portfolio, ranked #146.

Intact Investment Management first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $14.7M in Q4 2021. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Intact Investment Management held 11,900 shares of Amgen worth $4.31M as of Q2 2026.
  • Intact Investment Management sold 3,400 Amgen shares in Q2 2026, an estimated $1.16M.
  • Amgen made up 0.12% of Intact Investment Management's portfolio in Q2 2026, its #146 holding.
  • Intact Investment Management first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • Intact Investment Management's Amgen position peaked at $14.7M in Q4 2021.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.